Loading clinical trials...
Loading clinical trials...
Pioneering Verification of the Use of the Immunomodulatory Effect of Subthreshold Micropulse Laser Therapy (SML) in Retinitis Pigmentosa With an Attempt to Optimize 577 nm and 810 nm Laser Protocols
Conditions
Interventions
SML 577 nm
SML 810 nm
+1 more
Locations
1
Poland
First Department of Ophthalmology, Pomeranian Medical University
Szczecin, Poland
Start Date
September 1, 2024
Primary Completion Date
August 1, 2026
Completion Date
February 28, 2027
Last Updated
July 31, 2025
NCT07548944
NCT07292987
NCT06789445
NCT06787482
NCT07265895
NCT07266584
Lead Sponsor
Marta P. Wiącek
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions